MIRA
INFORM REPORT
|
Report Date : |
16.11.2007 |
IDENTIFICATION
DETAILS
|
Name : |
GLOBAL PHARMACEUTICALS (PRIVATE) LIMITED |
|
|
|
|
Registered Office : |
Plot # 204-205, Industrial
Traingle, Kahuta Road, Islamabad |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
1995 |
|
|
|
|
Com. Reg. No.: |
00000003923 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture & Marketing of Pharmaceutical Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
Business Name
GLOBAL PHARMACEUTICALS (PRIVATE) LIMITED
Full Address
Registered Address
& Factory
Plot # 204-205, Industrial
Traingle, Kahuta Road, Islamabad, Pakistan
Tel 92 (51) 4492032, 4492033, 4490817
Fax 92 (51) 4492034
Email globalpk@comsats.net.pk
Short Description Of Business
|
Nature of Business |
Manufacture & Marketing of Pharmaceutical Products |
|
Year Established |
1995 |
|
Registration # |
00000003923 |
Branches
|
Address |
2nd Floor, Redco Plaza, Jinnah
Avenue Blue Area, Islamabad, Pakistan |
|
Tel # |
92 (51) 2877275, 2878542 |
|
Fax # |
92 (51) 2879058 |
|
Address |
D-24, 6th Road, Satellite Town, Rawalpindi, Pakistan |
|
Tel # |
92 (51) 2278047, 2874175, 2870703 |
|
Fax # |
92 (51) 2870705 |
Auditors
Shahid Tariq & Co.
(Chartered
Accountants)
Office # 3, 1st Floor, Rajan Plaza, F-10 Markaz Islamabad, Pakistan
Legal Status
Subject Company was established as a Proprietorship business in 1995. In 2004, it was converted to Private Limited Company
|
Authorized Capital |
Rs. 100,000/- divided
into 10,000 shares of Rs. 10/- each |
|
Issued & Paid up Capital |
Rs. 10,000/- divided into
1,000 shares of Rs. 10/- each |
Details of Directors
|
Names |
Address |
Occupation |
Designation |
|
Mr. Mohammad Asad Mrs. Ayesha Farooq Mrs. Farzana Asad |
Plot # 204-205, Industrial Traingle, Kahuta Road, Islamabad Plot # 204-205, Industrial Traingle, Kahuta Road, Islamabad Plot # 204-205, Industrial Traingle, Kahuta Road, Islamabad |
Business Business Business |
Chief Executive Director Director |
Shareholders
|
Names of Shareholders |
No of Shares |
|
Mrs. Ayesha Farooq Mrs. Farzana Asad |
500 500 |
Associated Companies
(1) Global Distributors, Pakistan.
Products
ALERGOCIT, ANDRVIRON, APTIZOLE, ARTICURE, ARTINIL, ARTINIL-K, CEPZOLIN, CITOLIN, CITOPRAM, CLAVOPIN, COX-2 , CYCOLUNCT-N, DEPO ANDROGEN, DICON EYE DROPS, DICON-N, ECONOPHEN, ESOCUE, ESTROMAIN, FEMOCAL, FEMOCAL PLUS, FENADEX, FEROMALT, FEVONOR, FLOMIN, GLOBINAN, GLOVERINE, GLOVIAN-E, GLUCOLYTE, YNONIL, KAMIN, KETOLERG, LEVOFIN, LEVOLOL, LINCOLIDE, LUBRI, LUBRI PLUS, MECOMAX, MEDICIP, MEDROXY DEPO, METHOLON FORTE, METHOLON-N, NAFCIN, NEURO VITA, NEUROLIN, NEVROPIL, NORBAC, OFLOQUIN, ORTHOMIN, PATHONIL, PELTON, PELTON-C, PERIDAL, PIPRO, PIRACTIM, RIBAGENE, SPORONIL, STIG, THYROXINE, TRAMACURE, VEXOR
Number of Employees
156
Annual Sales Volume
|
Year |
In Pak Rupees |
|
2006 |
65,000,000/- (Estimated) |
Annual Production Volume
The capacity and production of the company’s plant is indeterminable
as it is multi-product and involves various processes of manufacture.
Trade Suppliers (Foreign)
(1) ROQUETTE
INTERNATIONAL, FRANCE.
(2) PURAC ASIA PTE LIMITED,
SINGAPORE.
(3) NORTH CHINA
PHARMACEUTICAL GROUP, CHINA.
(3) JIANGXI MEDICINES. AND HEALTH PRODUCTS, CHINA
Distributors Network
Mainly in Karachi,
Lahore, Multan & Peshawar
Bankers
ABN AMRO Bank, Pakistan.
Hong Kong Shanghai Banking Corporation, Pakistan.
Faysal Bank Limited, Pakistan.
Union Bank Limited, Pakistan.
Memberships
Pakistan Pharmaceutical
Manufacturers Association (PPMA)
Foreign Exchange Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 61.23 |
|
UK Pound |
1 |
Rs. 124.80 |
|
Euro |
1 |
Rs. 89.25 |
Comments
Subject Company was established in 1995 and is engaged in manufacture & marketing of Pharmaceutical Products. Trade relations are reported as fair. The Company can be considered for normal business dealings at usual trade terms and conditions.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)